Cited by 14Alzheimer's disease research and treatmentsAmyotrophic Lateral Sclerosis ResearchNeuroinflammation and Neurodegeneration Mechanisms

Immunolocalization of Smurf1 in Hirano bodies

Makioka, Kouki, Yamazaki, Tsuneo, Takatama, Masamitsu, Ikeda, Masaki, Okamoto, Koichi·2014·Journal of the Neurological Sciences

Abstract

The Smad ubiquitination regulatory factor 1 (Smurf1) is one of the E3 ubiquitin ligases and is related to multiple biological processes. Despite the various roles played by this protein, there is no report on the function of Smurf1 in neurodegeneration. Hirano bodies (HBs) are intracellular structures within neuronal processes and were first described in the hippocampus of individuals with amyotrophic lateral sclerosis and the parkinsonism-dementia complex of Guam. In addition, the number of HBs increases in the brains of patients with Alzheimer's disease (AD) compared with age-matched non-demented control individuals. In this study, we immunohistochemically demonstrated that Smurf1 localized in HBs in the brains of patients with AD by using plural anti-Smurf1 antibodies, and Smurf1 co-localized with HBs marker proteins by using confocal microscopy. Moreover, we demonstrated that Smurf1 localized in HB-like F-actin aggregates in a cell culture system via treatment with the actin-stabilizing toxin jasplakinolide (jpk). Smurf1 represents a novel protein component of HBs, to be included in an expanding list of HB-associated proteins.

Integrity signals

Registry

Crossref · 10.1016/j.jns.2013.09.028

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Actin-rich paracrystalline inclusions, so-called Hirano bodies, are found in brain histopathological samples of Alzheimer's disease and related tauopathies.

    “In agreement with the disease relevance of the Tau/actin interaction, actin-rich paracrystalline inclusions, so-called Hirano bodies, are found in brain histopathological samples of AD and related tauopathies24, 25.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Makioka, K., Yamazaki, T., Takatama, M., Ikeda, M., & Okamoto, K.
Affiliations
Gunma University (JP)
Venue
Journal of the Neurological Sciences
Publisher
Elsevier BV
Published
2014-01
Volume
336
Issue
1-2
Pages
24-28
ISSN
0022-510X (ISSN-L)
OpenAlex
W2163401136
Cited by
14
References
1
Citations by year
2025: 1 · 2024: 2 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 2
FWCI
0.69
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the Neurological Sciences (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ministry of Education, Culture, Sports, Science and Technology
  • Ministry of Health, Labour and Welfare
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Smurf1, Hirano bodies, Alzheimer's disease, E3 ubiquitin ligase, neurodegeneration, jasplakinolide, amyotrophic lateral sclerosis, parkinsonism-dementia complex of Guam, protein colocalization
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Inclusion Bodies, Female, HeLa Cells, Hippocampus, Humans, Male, Middle Aged, Ubiquitin-Protein Ligases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review